INS and Hyperglycemia: They also suggest that systemic bi-shRNAPDX-1 lipoplexes result in temporal, mild hyperglycemia emanating from suppression of PDX-1 within the islets of Langerhans with subsequent suppression of insulin and PP expression, correlating with alterations in islet cell cycle proteins and increased islet apoptosis.